Assessment of validity and safety in Enoxaparin administration soon after cesarean section.

Assessment of validity and safety in Enoxaparin administration soon after cesarean section. - Clinical assessment of Enoxaparin administration soon after cesarean section.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009068

Enrollment

160

Registered

2012-10-09

Start date

2012-10-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism (VTE)

Interventions

administrated group of unfractionated heparin calcium (Mochida) administrated group of Enoxaparin (Clexane)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women who delivered a baby/babies by cesarean section.

Exclusion criteria

Exclusion criteria: thrombocytopenia, acute bacterial endocarditis renal dysfunction (creatinine clearance less than 50 mL/min)

Design outcomes

Primary

Measure	Time frame
The incidence rate of VTE and other complications following cesarean section.	—

Countries

Japan

Contacts

Public ContactHiroaki Itoh

Hamamatsu University School of Medicine Obstetrics and Gynecology

hitou-endo@umin.ac.jp053-435-2309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026